FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.
Sirtex Medical’s salvage therapy for metastatic colorectal cancer should sustain high compound growth and returns, Morgan Stanley contends.
Fortescue Metals has outlined a joint venture deal with Brazil’s Vale for blending iron ore. Brokers mull the proposed benefits.
Weekly Update on ASX-listed companies buying in their own stock.
Peter Switzer of the Switzer Super Report discusses whether 2016 will be another “Sell in May” story.
Morgans assumes coverage of paint and hardware manufacturer, Dulux, believing the company’s strong brand profile will enable it to weather any downturn in the housing market.
Regis Healthcare will acquire a portfolio from Masonic Care Qld. Brokers mildly question the price of the acquisition but like the quality of the assets.
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Stockbroker Moelis thinks Appen is performing much better than market expectations.
2016 to date has featured much reduced volumes in the spot uranium market and an ongoing slide in prices.
Michael Gable of Fairmont Equities suggests the ASX200 is en route to 5350.
